Back to the main directory
EarningsReview / Equity
- Acrobatica SpA - Belle performance by MidCap Partners
- Svas Biosana S.p.A. - Higher Than Ever! by MidCap Partners
- AAL, STEEL US, STEEL CHINA, MT, CHINA CREDIT by BNP Paribas Exane
- Cimerli US commercial pause & increased discounts could weigh on FY25 outlook by BNP Paribas Exane
- Updating for FX by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- GALP - Prudent 2025 outlook, all eyes on Namibia; Buy by JB Capital Markets
- Your CAGNY Guidance Book by BNP Paribas Exane
- 顺络电子（002138 CH） by HSBC
- Q424 earnings postview (+15 questions for management) by BNP Paribas Exane
- Growth at a cost by BNP Paribas Exane
- 4QFY25E central capex pick-up weaker than it appears by BNP Paribas Exane
- Kinsus (3189 TT) by HSBC
- Mortgage recovery delayed but returns continue to rise: O/P by BNP Paribas Exane
- Shares could re-rate further by BNP Paribas Exane
- Cloudberry (Buy, TP: NOK13.50) - Powering forward by DnB Markets
- TietoEVRY (Sell, TP: EUR16.00) - Risk still skewed to the downside by DnB Markets
- Klaveness Combination Carriers (Buy, TP: NOK125.00) - Undervalued business model by DnB Markets
- Odfjell Technology (Buy, TP: NOK70.00) - Looking for H2 2025 growth by DnB Markets
- Aurora Eiendom (Buy, TP: NOK115.00) - Solid foundation and attractive valuation by DnB Markets
- Kitron (Buy, TP: NOK40.00) - Facing temporary margin headwind by DnB Markets
- Itaú BBA on BB Seguridade: 4Q24 Beat on Controlled Claims by Itau
- Bakkafrost - Buy/NOK 750 (800): No reason to be fed up with feed by Nordea
- Carrefour Brazil announcement: still not obvious to us by BNP Paribas Exane
- Ratos - Hold: Ongoing transformation by Nordea